Everyone Healthy Library
Guillain Barre Syndrome
Also Known As: Acute Inflammatory Polyneuropathy; Idiopathic Polyneuritis; Landry Guillain Barre Syndrome
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Condition overview
Attributes
Commonalityis common
Incidenceis approximately 1 in 50,000 people
Linked signs and symptoms
15Each sign/symptom opens its own page and links back to related conditions.
- Blood Pressure Below Normal (Hypotension)
- Breath Shortness (Dyspnoea)
- Distal Sensory Loss: Peripheral Neuropathy
- Drooling (Dribbling)
- Heart Rate Irregular (Arrhythmia)
- Immune Dysfunction
- Movement: Muscle Coordination Loss (Ataxia)
- Muscle Areflexia (Absence of Reflexes)
- Muscle Reflexes Below Normal (Hyporeflexia)
- Muscle Weakness
- Pain Muscle (Myalgia)
- Paralysis General
- Skin Tingling Or Numbness (Paresthesias)
- Swallowing Difficulty (Dysphagia)
- Weakness
Linked drugs / medications
0No linked drugs are listed yet.
Treatments, therapies and supportive options
12Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Medical therapy
3Lifestyle changes
1Alternative and complementary therapies
4Linked diagnostic tests and investigations
4These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
Biological and test markers
10This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
10- Albumin (Cerebrospinal Fluid, CSF)Reference range exampleAll: 10–35 mg/dL; All: 56–76 %Linked diagnostic tests2Cerebrospinal Fluid Albumin Concentration, Cerebrospinal Fluid Protein Electrophoresis
- Alpha-1-Globulin (Cerebrospinal Fluid, CSF)Reference range exampleAll: 2–7 %Linked diagnostic tests1Cerebrospinal Fluid Protein Electrophoresis
- Alpha-2-Globulin (Cerebrospinal Fluid, CSF)Reference range exampleAll: 4–12 %Linked diagnostic tests1Cerebrospinal Fluid Protein Electrophoresis
- Beta-Globulin (Cerebrospinal Fluid, CSF)Reference range exampleAll: 8–18 %Linked diagnostic tests1Cerebrospinal Fluid Protein Electrophoresis
- Cerebrospinal Fluid Immunoglobulin G (IgG)Reference range exampleAll: 0–43 mg/dLLinked diagnostic tests1Cerebrospinal Fluid Immunoglobulin G (IgG) Concentration
- Cerebrospinal Fluid LeukocytesReference range exampleAdult ( > 16y): 0–5 /µL; 1y - 6y: 0–20 /µLLinked diagnostic tests1Cerebrospinal Fluid White Cell Differential
- Cerebrospinal Fluid Lymphocyte DifferentialReference range exampleAll: 41–82 %Linked diagnostic tests1Cerebrospinal Fluid White Cell Differential
- Gamma-Globulin (Cerebrospinal Fluid, CSF)Reference range exampleAll: 3–12 %Linked diagnostic tests1Cerebrospinal Fluid Protein Electrophoresis
- IgG (Cerebrospinal Fluid, CSF)Reference range exampleAll: 0–5 mg/dLLinked diagnostic tests1Cerebrospinal Fluid Protein Electrophoresis
- PrealbuminReference range exampleAll: 2–7 %Linked diagnostic tests1Cerebrospinal Fluid Protein Electrophoresis
Often decreased
0No markers in this group.
Other associated markers
0No markers in this group.
Introduction / full article
Guillain Barre Syndrome
Guillain Barre Syndrome
The cause of Guillain-Barre Syndrome is still unknown but it happens when the immune system affects the function of nerves. This condition causes weakness and the symptoms start in the arms and legs but can easily spread throughout the whole body. Extreme cases of Guillain-Barre Syndrome can cause paralysation. Guillain-Barre Syndrome is a rare condition and the first signs are unnoticeable. Symptoms include needle-like pain in the extremities, weakness, fatigue, extreme pain in the lower back, fast heartbeat, instability, affected eye movement, and difficulty in breathing, speaking, and eating. Guillain-Barre Syndrome can spread throughout the body in just four weeks from the first onset of symptoms.